YUCAIPA, Calif., July 15, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company's CEO, Scott Sand, will talk on the live radio program of The Money Channel's American Scene Radio, with host Steve Crowley, today at 11:49am eastern standard time.
According to the World Health Organization (WHO), Chronic Obstructive Pulmonary Disease (COPD) kills an estimated average of one person every 10 seconds. In 2005, COPD contributed to 5% of deaths worldwide.
COPD illness is on a continuous growing curve. The COPD disease cannot be cured, but treatments may assist in slowing disease progression. Also, the COPD market is growing every year. Therefore, demand for oxygen and other respiratory products will continue to increase.
Ingen's strategic consulting partner for government contract procurement, KGMA Business Solutions, has introduced the new Smart Nasal Cannula to various military and government branches. Kenneth Kurk, President of the Texas based KGMA Business Solutions, has indicated in a written report that there is $1.4M dollars made available before the end of this year for the Ingen products with the various branches they have visited. Mr. Kurk and his highly experienced staff are pushing to close purchase contracts for Ingen.
"Companies like Ingen are helping to meet this growing demand which investors are taking note on," Stated Scott Sand, CEO and Chairman of the Board. Sand further stated, "Although our commercial sales are increasing as we ship products everyday to patients, government VA Hospitals provide medical care to literally millions of veterans ranging from young adults to seniors. Many of these veterans suffer from COPD and utilize home oxygen services provided through the government. Our new Smart Nasal Cannula will be recognized to improve the home oxygen therapy for these patients and provide other benefits such as a reduction in service calls and equipment problems related to home oxygen therapy. There is also interest with the Department of Defense regarding using our medical product with Army facilities. Our larger market is export sales for Europe and Asia. We have recently demonstrated our management strength with our ISO Certification, and we anticipate receiving our CE, Mark, to sell our products and fulfill backorders for our export sales."
Ingen announced on July 7th that the company's strategic government contract consultant, KGMA Business Solutions, has scheduled two major tradeshows for August and September 2010. It will debut its new Smart Nasal Cannula on August 10 - 11, 2010, at the 13th Annual Force Health Protection Conference (FHP) in Phoenix, Arizona; and again on September 8th, 2010, at the Fort Detrick Vendor Day in Frederick, Maryland.
http://www.eventsinamerica.com/events/13th_annual_force_health_protection_conference/ev4a9c3043dc273/
http://www.detrick.army.mil/services/vendorday.cfm
http://www.smartnasalcannula.com/
http://www.ingenpulseoximeter.com/
About Ingen:
Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.